[
  {
    "text": "Minami-ku, Kyoto 601-8550, Japan (\"Distributor'). Zogenix and Distributor may be referred to individually as a \"Party\"' and",
    "bbox": [
      111,
      288,
      1000,
      302
    ],
    "label": 2,
    "category": "Parties"
  },
  {
    "text": "collectively as the \"Parties\"'",
    "bbox": [
      114,
      308,
      353,
      320
    ],
    "label": 2,
    "category": "Parties"
  },
  {
    "text": "This DISTRIBUTORSHIP AGREEMENT (\"Agreement') is entered into as of March 18, 2019 (the \"Effective",
    "bbox": [
      179,
      230,
      1000,
      245
    ],
    "label": 3,
    "category": "Agreement Date"
  },
  {
    "text": "This DISTRIBUTORSHIP AGREEMENT (\"Agreement') is entered into as of March 18, 2019 (the \"Effective",
    "bbox": [
      179,
      230,
      1000,
      245
    ],
    "label": 4,
    "category": "Effective Date"
  },
  {
    "text": "DISTRIBUTORSHIP AGREEMENT",
    "bbox": [
      490,
      197,
      843,
      207
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "This DISTRIBUTORSHIP AGREEMENT (\"Agreement') is entered into as of March 18, 2019 (the \"Effective",
    "bbox": [
      179,
      230,
      1000,
      245
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "Date') by and between ZOGENIX, INC., having a place of business at 5959 Horton Street, Suite 500, Emeryville, California",
    "bbox": [
      110,
      249,
      1000,
      265
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "94608( \"Zogenix') and Nippon Shinyaku Company, Ltd., having a place of business at 14, Nishinosho-Monguchi-cho, Kisshoin,",
    "bbox": [
      113,
      269,
      1000,
      283
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "Minami-ku, Kyoto 601-8550, Japan (\"Distributor'). Zogenix and Distributor may be referred to individually as a \"Party\"' and",
    "bbox": [
      111,
      288,
      1000,
      302
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "collectively as the \"Parties\"'",
    "bbox": [
      114,
      308,
      353,
      320
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "RECITALS",
    "bbox": [
      611,
      342,
      721,
      354
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "WHEREAS, Zogenix is developing its proprietary fenfluramine product, known as Fintepla..",
    "bbox": [
      179,
      375,
      972,
      392
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "WHEREAS, Zogenix wishes to commercialize such product through a distributor that will promote, market, sell and",
    "bbox": [
      181,
      412,
      1000,
      425
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "distribute such product within the Territory;.",
    "bbox": [
      112,
      429,
      475,
      446
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "WHEREAS, Distributor has the ability to promote, market, sell and distribute such product within the Territory for the",
    "bbox": [
      179,
      465,
      1000,
      480
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "treatment of Dravet syndrome and Lennox-Gastaut syndrome and any additional indications approved in the Territory, and wishes",
    "bbox": [
      113,
      486,
      1000,
      499
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "to be Zogenix's exclusive distributor of such product for such indications within the Territory, and Zogenix is willing to grant to",
    "bbox": [
      111,
      504,
      1000,
      518
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "Distributor such exclusive distribution rights on the terms and conditions set forth in this Agreement; and",
    "bbox": [
      111,
      522,
      988,
      537
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "WHEREAS, Zogenix agrees to manufacture (or have manufactured) and sell to Distributor such product for such",
    "bbox": [
      179,
      557,
      1000,
      573
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "commercialization activities in the Territory, on the terms and conditions set forth in this Agreement and in a separate supply",
    "bbox": [
      111,
      576,
      1000,
      592
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "agreement to be entered into by the Parties..",
    "bbox": [
      112,
      596,
      480,
      611
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "NOw, THEREFORE, in consideration of the foregoing premises and the mutual covenants herein contained, and for",
    "bbox": [
      179,
      631,
      1000,
      645
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Zogenix and Distributor",
    "bbox": [
      114,
      651,
      1000,
      664
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "hereby agree as follows:.",
    "bbox": [
      113,
      670,
      315,
      682
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "ARTICLE 1.",
    "bbox": [
      608,
      704,
      727,
      716
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "DEFINITIONS",
    "bbox": [
      594,
      723,
      738,
      734
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "1.1 \"Affiliate\"' of a Party means any entity that, directly or indirectly, through one or more intermediaries, controls, is",
    "bbox": [
      179,
      756,
      1000,
      773
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "controlled by, or is under common control with such Party, as the case may be, but for only so long as such control exists. As used",
    "bbox": [
      114,
      777,
      1000,
      790
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "in this Section 1.1, \"control' means (a) to possess, directly or indirectly, the power to direct the management or policies of an",
    "bbox": [
      111,
      795,
      1000,
      810
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "entity, whether through ownership of voting securities, or by contract relating to voting rights or corporate governance; or (b) direct",
    "bbox": [
      111,
      815,
      1000,
      829
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "or indirect beneficial ownership of more than fifty percent (50%) (or such lesser percentage which is the maximum allowed to be",
    "bbox": [
      111,
      833,
      1000,
      849
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "owned by a foreign corporation in a particular jurisdiction) of the voting share capital or other equity interest in such entity",
    "bbox": [
      114,
      854,
      1000,
      866
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "US-DOCS\\105216871.19",
    "bbox": [
      112,
      969,
      277,
      978
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "Source: ZOGENIX, INC., 10-Q, 5/9/2019",
    "bbox": [
      133,
      1000,
      451,
      1000
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "DISTRIBUTORSHIP AGREEMENT",
    "bbox": [
      490,
      197,
      843,
      207
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "This DISTRIBUTORSHIP AGREEMENT (\"Agreement') is entered into as of March 18, 2019 (the \"Effective",
    "bbox": [
      179,
      230,
      1000,
      245
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "Date') by and between ZOGENIX, INC., having a place of business at 5959 Horton Street, Suite 500, Emeryville, California",
    "bbox": [
      110,
      249,
      1000,
      265
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "94608( \"Zogenix') and Nippon Shinyaku Company, Ltd., having a place of business at 14, Nishinosho-Monguchi-cho, Kisshoin,",
    "bbox": [
      113,
      269,
      1000,
      283
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "Minami-ku, Kyoto 601-8550, Japan (\"Distributor'). Zogenix and Distributor may be referred to individually as a \"Party\"' and",
    "bbox": [
      111,
      288,
      1000,
      302
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "collectively as the \"Parties\"'",
    "bbox": [
      114,
      308,
      353,
      320
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "RECITALS",
    "bbox": [
      611,
      342,
      721,
      354
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "WHEREAS, Zogenix is developing its proprietary fenfluramine product, known as Fintepla..",
    "bbox": [
      179,
      375,
      972,
      392
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "WHEREAS, Zogenix wishes to commercialize such product through a distributor that will promote, market, sell and",
    "bbox": [
      181,
      412,
      1000,
      425
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "distribute such product within the Territory;.",
    "bbox": [
      112,
      429,
      475,
      446
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "WHEREAS, Distributor has the ability to promote, market, sell and distribute such product within the Territory for the",
    "bbox": [
      179,
      465,
      1000,
      480
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "treatment of Dravet syndrome and Lennox-Gastaut syndrome and any additional indications approved in the Territory, and wishes",
    "bbox": [
      113,
      486,
      1000,
      499
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "to be Zogenix's exclusive distributor of such product for such indications within the Territory, and Zogenix is willing to grant to",
    "bbox": [
      111,
      504,
      1000,
      518
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "Distributor such exclusive distribution rights on the terms and conditions set forth in this Agreement; and",
    "bbox": [
      111,
      522,
      988,
      537
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "WHEREAS, Zogenix agrees to manufacture (or have manufactured) and sell to Distributor such product for such",
    "bbox": [
      179,
      557,
      1000,
      573
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "commercialization activities in the Territory, on the terms and conditions set forth in this Agreement and in a separate supply",
    "bbox": [
      111,
      576,
      1000,
      592
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "agreement to be entered into by the Parties..",
    "bbox": [
      112,
      596,
      480,
      611
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "NOw, THEREFORE, in consideration of the foregoing premises and the mutual covenants herein contained, and for",
    "bbox": [
      179,
      631,
      1000,
      645
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Zogenix and Distributor",
    "bbox": [
      114,
      651,
      1000,
      664
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "hereby agree as follows:.",
    "bbox": [
      113,
      670,
      315,
      682
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "ARTICLE 1.",
    "bbox": [
      608,
      704,
      727,
      716
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "DEFINITIONS",
    "bbox": [
      594,
      723,
      738,
      734
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "1.1 \"Affiliate\"' of a Party means any entity that, directly or indirectly, through one or more intermediaries, controls, is",
    "bbox": [
      179,
      756,
      1000,
      773
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "controlled by, or is under common control with such Party, as the case may be, but for only so long as such control exists. As used",
    "bbox": [
      114,
      777,
      1000,
      790
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "in this Section 1.1, \"control' means (a) to possess, directly or indirectly, the power to direct the management or policies of an",
    "bbox": [
      111,
      795,
      1000,
      810
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "entity, whether through ownership of voting securities, or by contract relating to voting rights or corporate governance; or (b) direct",
    "bbox": [
      111,
      815,
      1000,
      829
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "or indirect beneficial ownership of more than fifty percent (50%) (or such lesser percentage which is the maximum allowed to be",
    "bbox": [
      111,
      833,
      1000,
      849
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "owned by a foreign corporation in a particular jurisdiction) of the voting share capital or other equity interest in such entity",
    "bbox": [
      114,
      854,
      1000,
      866
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "US-DOCS\\105216871.19",
    "bbox": [
      112,
      969,
      277,
      978
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "Source: ZOGENIX, INC., 10-Q, 5/9/2019",
    "bbox": [
      133,
      1000,
      451,
      1000
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "DISTRIBUTORSHIP AGREEMENT",
    "bbox": [
      490,
      197,
      843,
      207
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "This DISTRIBUTORSHIP AGREEMENT (\"Agreement') is entered into as of March 18, 2019 (the \"Effective",
    "bbox": [
      179,
      230,
      1000,
      245
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Date') by and between ZOGENIX, INC., having a place of business at 5959 Horton Street, Suite 500, Emeryville, California",
    "bbox": [
      110,
      249,
      1000,
      265
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "94608( \"Zogenix') and Nippon Shinyaku Company, Ltd., having a place of business at 14, Nishinosho-Monguchi-cho, Kisshoin,",
    "bbox": [
      113,
      269,
      1000,
      283
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Minami-ku, Kyoto 601-8550, Japan (\"Distributor'). Zogenix and Distributor may be referred to individually as a \"Party\"' and",
    "bbox": [
      111,
      288,
      1000,
      302
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "collectively as the \"Parties\"'",
    "bbox": [
      114,
      308,
      353,
      320
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "RECITALS",
    "bbox": [
      611,
      342,
      721,
      354
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "WHEREAS, Zogenix is developing its proprietary fenfluramine product, known as Fintepla..",
    "bbox": [
      179,
      375,
      972,
      392
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "WHEREAS, Zogenix wishes to commercialize such product through a distributor that will promote, market, sell and",
    "bbox": [
      181,
      412,
      1000,
      425
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "distribute such product within the Territory;.",
    "bbox": [
      112,
      429,
      475,
      446
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "WHEREAS, Distributor has the ability to promote, market, sell and distribute such product within the Territory for the",
    "bbox": [
      179,
      465,
      1000,
      480
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "treatment of Dravet syndrome and Lennox-Gastaut syndrome and any additional indications approved in the Territory, and wishes",
    "bbox": [
      113,
      486,
      1000,
      499
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "to be Zogenix's exclusive distributor of such product for such indications within the Territory, and Zogenix is willing to grant to",
    "bbox": [
      111,
      504,
      1000,
      518
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Distributor such exclusive distribution rights on the terms and conditions set forth in this Agreement; and",
    "bbox": [
      111,
      522,
      988,
      537
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "WHEREAS, Zogenix agrees to manufacture (or have manufactured) and sell to Distributor such product for such",
    "bbox": [
      179,
      557,
      1000,
      573
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "commercialization activities in the Territory, on the terms and conditions set forth in this Agreement and in a separate supply",
    "bbox": [
      111,
      576,
      1000,
      592
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "agreement to be entered into by the Parties..",
    "bbox": [
      112,
      596,
      480,
      611
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "NOw, THEREFORE, in consideration of the foregoing premises and the mutual covenants herein contained, and for",
    "bbox": [
      179,
      631,
      1000,
      645
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Zogenix and Distributor",
    "bbox": [
      114,
      651,
      1000,
      664
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "hereby agree as follows:.",
    "bbox": [
      113,
      670,
      315,
      682
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "ARTICLE 1.",
    "bbox": [
      608,
      704,
      727,
      716
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "DEFINITIONS",
    "bbox": [
      594,
      723,
      738,
      734
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.1 \"Affiliate\"' of a Party means any entity that, directly or indirectly, through one or more intermediaries, controls, is",
    "bbox": [
      179,
      756,
      1000,
      773
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "controlled by, or is under common control with such Party, as the case may be, but for only so long as such control exists. As used",
    "bbox": [
      114,
      777,
      1000,
      790
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "in this Section 1.1, \"control' means (a) to possess, directly or indirectly, the power to direct the management or policies of an",
    "bbox": [
      111,
      795,
      1000,
      810
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "entity, whether through ownership of voting securities, or by contract relating to voting rights or corporate governance; or (b) direct",
    "bbox": [
      111,
      815,
      1000,
      829
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "or indirect beneficial ownership of more than fifty percent (50%) (or such lesser percentage which is the maximum allowed to be",
    "bbox": [
      111,
      833,
      1000,
      849
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "owned by a foreign corporation in a particular jurisdiction) of the voting share capital or other equity interest in such entity",
    "bbox": [
      114,
      854,
      1000,
      866
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "US-DOCS\\105216871.19",
    "bbox": [
      112,
      969,
      277,
      978
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Source: ZOGENIX, INC., 10-Q, 5/9/2019",
    "bbox": [
      133,
      1000,
      451,
      1000
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "DISTRIBUTORSHIP AGREEMENT",
    "bbox": [
      490,
      197,
      843,
      207
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "This DISTRIBUTORSHIP AGREEMENT (\"Agreement') is entered into as of March 18, 2019 (the \"Effective",
    "bbox": [
      179,
      230,
      1000,
      245
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Date') by and between ZOGENIX, INC., having a place of business at 5959 Horton Street, Suite 500, Emeryville, California",
    "bbox": [
      110,
      249,
      1000,
      265
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "94608( \"Zogenix') and Nippon Shinyaku Company, Ltd., having a place of business at 14, Nishinosho-Monguchi-cho, Kisshoin,",
    "bbox": [
      113,
      269,
      1000,
      283
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Minami-ku, Kyoto 601-8550, Japan (\"Distributor'). Zogenix and Distributor may be referred to individually as a \"Party\"' and",
    "bbox": [
      111,
      288,
      1000,
      302
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "collectively as the \"Parties\"'",
    "bbox": [
      114,
      308,
      353,
      320
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "RECITALS",
    "bbox": [
      611,
      342,
      721,
      354
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "WHEREAS, Zogenix is developing its proprietary fenfluramine product, known as Fintepla..",
    "bbox": [
      179,
      375,
      972,
      392
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "WHEREAS, Zogenix wishes to commercialize such product through a distributor that will promote, market, sell and",
    "bbox": [
      181,
      412,
      1000,
      425
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "distribute such product within the Territory;.",
    "bbox": [
      112,
      429,
      475,
      446
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "WHEREAS, Distributor has the ability to promote, market, sell and distribute such product within the Territory for the",
    "bbox": [
      179,
      465,
      1000,
      480
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "treatment of Dravet syndrome and Lennox-Gastaut syndrome and any additional indications approved in the Territory, and wishes",
    "bbox": [
      113,
      486,
      1000,
      499
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "to be Zogenix's exclusive distributor of such product for such indications within the Territory, and Zogenix is willing to grant to",
    "bbox": [
      111,
      504,
      1000,
      518
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Distributor such exclusive distribution rights on the terms and conditions set forth in this Agreement; and",
    "bbox": [
      111,
      522,
      988,
      537
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "WHEREAS, Zogenix agrees to manufacture (or have manufactured) and sell to Distributor such product for such",
    "bbox": [
      179,
      557,
      1000,
      573
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "commercialization activities in the Territory, on the terms and conditions set forth in this Agreement and in a separate supply",
    "bbox": [
      111,
      576,
      1000,
      592
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "agreement to be entered into by the Parties..",
    "bbox": [
      112,
      596,
      480,
      611
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "NOw, THEREFORE, in consideration of the foregoing premises and the mutual covenants herein contained, and for",
    "bbox": [
      179,
      631,
      1000,
      645
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Zogenix and Distributor",
    "bbox": [
      114,
      651,
      1000,
      664
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "hereby agree as follows:.",
    "bbox": [
      113,
      670,
      315,
      682
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "ARTICLE 1.",
    "bbox": [
      608,
      704,
      727,
      716
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "DEFINITIONS",
    "bbox": [
      594,
      723,
      738,
      734
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.1 \"Affiliate\"' of a Party means any entity that, directly or indirectly, through one or more intermediaries, controls, is",
    "bbox": [
      179,
      756,
      1000,
      773
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "controlled by, or is under common control with such Party, as the case may be, but for only so long as such control exists. As used",
    "bbox": [
      114,
      777,
      1000,
      790
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "in this Section 1.1, \"control' means (a) to possess, directly or indirectly, the power to direct the management or policies of an",
    "bbox": [
      111,
      795,
      1000,
      810
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "entity, whether through ownership of voting securities, or by contract relating to voting rights or corporate governance; or (b) direct",
    "bbox": [
      111,
      815,
      1000,
      829
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "or indirect beneficial ownership of more than fifty percent (50%) (or such lesser percentage which is the maximum allowed to be",
    "bbox": [
      111,
      833,
      1000,
      849
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "owned by a foreign corporation in a particular jurisdiction) of the voting share capital or other equity interest in such entity",
    "bbox": [
      114,
      854,
      1000,
      866
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "US-DOCS\\105216871.19",
    "bbox": [
      112,
      969,
      277,
      978
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Source: ZOGENIX, INC., 10-Q, 5/9/2019",
    "bbox": [
      133,
      1000,
      451,
      1000
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "DISTRIBUTORSHIP AGREEMENT",
    "bbox": [
      490,
      197,
      843,
      207
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "This DISTRIBUTORSHIP AGREEMENT (\"Agreement') is entered into as of March 18, 2019 (the \"Effective",
    "bbox": [
      179,
      230,
      1000,
      245
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "Date') by and between ZOGENIX, INC., having a place of business at 5959 Horton Street, Suite 500, Emeryville, California",
    "bbox": [
      110,
      249,
      1000,
      265
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "94608( \"Zogenix') and Nippon Shinyaku Company, Ltd., having a place of business at 14, Nishinosho-Monguchi-cho, Kisshoin,",
    "bbox": [
      113,
      269,
      1000,
      283
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "Minami-ku, Kyoto 601-8550, Japan (\"Distributor'). Zogenix and Distributor may be referred to individually as a \"Party\"' and",
    "bbox": [
      111,
      288,
      1000,
      302
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "collectively as the \"Parties\"'",
    "bbox": [
      114,
      308,
      353,
      320
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "RECITALS",
    "bbox": [
      611,
      342,
      721,
      354
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "WHEREAS, Zogenix is developing its proprietary fenfluramine product, known as Fintepla..",
    "bbox": [
      179,
      375,
      972,
      392
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "WHEREAS, Zogenix wishes to commercialize such product through a distributor that will promote, market, sell and",
    "bbox": [
      181,
      412,
      1000,
      425
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "distribute such product within the Territory;.",
    "bbox": [
      112,
      429,
      475,
      446
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "WHEREAS, Distributor has the ability to promote, market, sell and distribute such product within the Territory for the",
    "bbox": [
      179,
      465,
      1000,
      480
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "treatment of Dravet syndrome and Lennox-Gastaut syndrome and any additional indications approved in the Territory, and wishes",
    "bbox": [
      113,
      486,
      1000,
      499
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "to be Zogenix's exclusive distributor of such product for such indications within the Territory, and Zogenix is willing to grant to",
    "bbox": [
      111,
      504,
      1000,
      518
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "Distributor such exclusive distribution rights on the terms and conditions set forth in this Agreement; and",
    "bbox": [
      111,
      522,
      988,
      537
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "WHEREAS, Zogenix agrees to manufacture (or have manufactured) and sell to Distributor such product for such",
    "bbox": [
      179,
      557,
      1000,
      573
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "commercialization activities in the Territory, on the terms and conditions set forth in this Agreement and in a separate supply",
    "bbox": [
      111,
      576,
      1000,
      592
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "agreement to be entered into by the Parties..",
    "bbox": [
      112,
      596,
      480,
      611
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "NOw, THEREFORE, in consideration of the foregoing premises and the mutual covenants herein contained, and for",
    "bbox": [
      179,
      631,
      1000,
      645
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Zogenix and Distributor",
    "bbox": [
      114,
      651,
      1000,
      664
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "hereby agree as follows:.",
    "bbox": [
      113,
      670,
      315,
      682
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "ARTICLE 1.",
    "bbox": [
      608,
      704,
      727,
      716
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "DEFINITIONS",
    "bbox": [
      594,
      723,
      738,
      734
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "1.1 \"Affiliate\"' of a Party means any entity that, directly or indirectly, through one or more intermediaries, controls, is",
    "bbox": [
      179,
      756,
      1000,
      773
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "controlled by, or is under common control with such Party, as the case may be, but for only so long as such control exists. As used",
    "bbox": [
      114,
      777,
      1000,
      790
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "in this Section 1.1, \"control' means (a) to possess, directly or indirectly, the power to direct the management or policies of an",
    "bbox": [
      111,
      795,
      1000,
      810
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "entity, whether through ownership of voting securities, or by contract relating to voting rights or corporate governance; or (b) direct",
    "bbox": [
      111,
      815,
      1000,
      829
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "or indirect beneficial ownership of more than fifty percent (50%) (or such lesser percentage which is the maximum allowed to be",
    "bbox": [
      111,
      833,
      1000,
      849
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "owned by a foreign corporation in a particular jurisdiction) of the voting share capital or other equity interest in such entity",
    "bbox": [
      114,
      854,
      1000,
      866
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "US-DOCS\\105216871.19",
    "bbox": [
      112,
      969,
      277,
      978
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "Source: ZOGENIX, INC., 10-Q, 5/9/2019",
    "bbox": [
      133,
      1000,
      451,
      1000
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "DISTRIBUTORSHIP AGREEMENT",
    "bbox": [
      490,
      197,
      843,
      207
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "This DISTRIBUTORSHIP AGREEMENT (\"Agreement') is entered into as of March 18, 2019 (the \"Effective",
    "bbox": [
      179,
      230,
      1000,
      245
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "Date') by and between ZOGENIX, INC., having a place of business at 5959 Horton Street, Suite 500, Emeryville, California",
    "bbox": [
      110,
      249,
      1000,
      265
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "94608( \"Zogenix') and Nippon Shinyaku Company, Ltd., having a place of business at 14, Nishinosho-Monguchi-cho, Kisshoin,",
    "bbox": [
      113,
      269,
      1000,
      283
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "Minami-ku, Kyoto 601-8550, Japan (\"Distributor'). Zogenix and Distributor may be referred to individually as a \"Party\"' and",
    "bbox": [
      111,
      288,
      1000,
      302
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "collectively as the \"Parties\"'",
    "bbox": [
      114,
      308,
      353,
      320
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "RECITALS",
    "bbox": [
      611,
      342,
      721,
      354
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "WHEREAS, Zogenix is developing its proprietary fenfluramine product, known as Fintepla..",
    "bbox": [
      179,
      375,
      972,
      392
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "WHEREAS, Zogenix wishes to commercialize such product through a distributor that will promote, market, sell and",
    "bbox": [
      181,
      412,
      1000,
      425
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "distribute such product within the Territory;.",
    "bbox": [
      112,
      429,
      475,
      446
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "WHEREAS, Distributor has the ability to promote, market, sell and distribute such product within the Territory for the",
    "bbox": [
      179,
      465,
      1000,
      480
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "treatment of Dravet syndrome and Lennox-Gastaut syndrome and any additional indications approved in the Territory, and wishes",
    "bbox": [
      113,
      486,
      1000,
      499
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "to be Zogenix's exclusive distributor of such product for such indications within the Territory, and Zogenix is willing to grant to",
    "bbox": [
      111,
      504,
      1000,
      518
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "Distributor such exclusive distribution rights on the terms and conditions set forth in this Agreement; and",
    "bbox": [
      111,
      522,
      988,
      537
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "WHEREAS, Zogenix agrees to manufacture (or have manufactured) and sell to Distributor such product for such",
    "bbox": [
      179,
      557,
      1000,
      573
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "commercialization activities in the Territory, on the terms and conditions set forth in this Agreement and in a separate supply",
    "bbox": [
      111,
      576,
      1000,
      592
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "agreement to be entered into by the Parties..",
    "bbox": [
      112,
      596,
      480,
      611
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "NOw, THEREFORE, in consideration of the foregoing premises and the mutual covenants herein contained, and for",
    "bbox": [
      179,
      631,
      1000,
      645
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Zogenix and Distributor",
    "bbox": [
      114,
      651,
      1000,
      664
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "hereby agree as follows:.",
    "bbox": [
      113,
      670,
      315,
      682
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "ARTICLE 1.",
    "bbox": [
      608,
      704,
      727,
      716
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "DEFINITIONS",
    "bbox": [
      594,
      723,
      738,
      734
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "1.1 \"Affiliate\"' of a Party means any entity that, directly or indirectly, through one or more intermediaries, controls, is",
    "bbox": [
      179,
      756,
      1000,
      773
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "controlled by, or is under common control with such Party, as the case may be, but for only so long as such control exists. As used",
    "bbox": [
      114,
      777,
      1000,
      790
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "in this Section 1.1, \"control' means (a) to possess, directly or indirectly, the power to direct the management or policies of an",
    "bbox": [
      111,
      795,
      1000,
      810
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "entity, whether through ownership of voting securities, or by contract relating to voting rights or corporate governance; or (b) direct",
    "bbox": [
      111,
      815,
      1000,
      829
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "or indirect beneficial ownership of more than fifty percent (50%) (or such lesser percentage which is the maximum allowed to be",
    "bbox": [
      111,
      833,
      1000,
      849
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "owned by a foreign corporation in a particular jurisdiction) of the voting share capital or other equity interest in such entity",
    "bbox": [
      114,
      854,
      1000,
      866
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "US-DOCS\\105216871.19",
    "bbox": [
      112,
      969,
      277,
      978
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "Source: ZOGENIX, INC., 10-Q, 5/9/2019",
    "bbox": [
      133,
      1000,
      451,
      1000
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "DISTRIBUTORSHIP AGREEMENT",
    "bbox": [
      490,
      197,
      843,
      207
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "This DISTRIBUTORSHIP AGREEMENT (\"Agreement') is entered into as of March 18, 2019 (the \"Effective",
    "bbox": [
      179,
      230,
      1000,
      245
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "Date') by and between ZOGENIX, INC., having a place of business at 5959 Horton Street, Suite 500, Emeryville, California",
    "bbox": [
      110,
      249,
      1000,
      265
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "94608( \"Zogenix') and Nippon Shinyaku Company, Ltd., having a place of business at 14, Nishinosho-Monguchi-cho, Kisshoin,",
    "bbox": [
      113,
      269,
      1000,
      283
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "Minami-ku, Kyoto 601-8550, Japan (\"Distributor'). Zogenix and Distributor may be referred to individually as a \"Party\"' and",
    "bbox": [
      111,
      288,
      1000,
      302
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "collectively as the \"Parties\"'",
    "bbox": [
      114,
      308,
      353,
      320
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "RECITALS",
    "bbox": [
      611,
      342,
      721,
      354
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "WHEREAS, Zogenix is developing its proprietary fenfluramine product, known as Fintepla..",
    "bbox": [
      179,
      375,
      972,
      392
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "WHEREAS, Zogenix wishes to commercialize such product through a distributor that will promote, market, sell and",
    "bbox": [
      181,
      412,
      1000,
      425
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "distribute such product within the Territory;.",
    "bbox": [
      112,
      429,
      475,
      446
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "WHEREAS, Distributor has the ability to promote, market, sell and distribute such product within the Territory for the",
    "bbox": [
      179,
      465,
      1000,
      480
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "treatment of Dravet syndrome and Lennox-Gastaut syndrome and any additional indications approved in the Territory, and wishes",
    "bbox": [
      113,
      486,
      1000,
      499
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "to be Zogenix's exclusive distributor of such product for such indications within the Territory, and Zogenix is willing to grant to",
    "bbox": [
      111,
      504,
      1000,
      518
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "Distributor such exclusive distribution rights on the terms and conditions set forth in this Agreement; and",
    "bbox": [
      111,
      522,
      988,
      537
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "WHEREAS, Zogenix agrees to manufacture (or have manufactured) and sell to Distributor such product for such",
    "bbox": [
      179,
      557,
      1000,
      573
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "commercialization activities in the Territory, on the terms and conditions set forth in this Agreement and in a separate supply",
    "bbox": [
      111,
      576,
      1000,
      592
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "agreement to be entered into by the Parties..",
    "bbox": [
      112,
      596,
      480,
      611
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "NOw, THEREFORE, in consideration of the foregoing premises and the mutual covenants herein contained, and for",
    "bbox": [
      179,
      631,
      1000,
      645
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Zogenix and Distributor",
    "bbox": [
      114,
      651,
      1000,
      664
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "hereby agree as follows:.",
    "bbox": [
      113,
      670,
      315,
      682
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "ARTICLE 1.",
    "bbox": [
      608,
      704,
      727,
      716
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "DEFINITIONS",
    "bbox": [
      594,
      723,
      738,
      734
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "1.1 \"Affiliate\"' of a Party means any entity that, directly or indirectly, through one or more intermediaries, controls, is",
    "bbox": [
      179,
      756,
      1000,
      773
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "controlled by, or is under common control with such Party, as the case may be, but for only so long as such control exists. As used",
    "bbox": [
      114,
      777,
      1000,
      790
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "in this Section 1.1, \"control' means (a) to possess, directly or indirectly, the power to direct the management or policies of an",
    "bbox": [
      111,
      795,
      1000,
      810
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "entity, whether through ownership of voting securities, or by contract relating to voting rights or corporate governance; or (b) direct",
    "bbox": [
      111,
      815,
      1000,
      829
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "or indirect beneficial ownership of more than fifty percent (50%) (or such lesser percentage which is the maximum allowed to be",
    "bbox": [
      111,
      833,
      1000,
      849
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "owned by a foreign corporation in a particular jurisdiction) of the voting share capital or other equity interest in such entity",
    "bbox": [
      114,
      854,
      1000,
      866
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "US-DOCS\\105216871.19",
    "bbox": [
      112,
      969,
      277,
      978
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "Source: ZOGENIX, INC., 10-Q, 5/9/2019",
    "bbox": [
      133,
      1000,
      451,
      1000
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  }
]